The EQUIPD study is an efficient cluster randomised trial of a quality improvement collaborative (QIC) aligned to the National Diabetes Audit that seeks to enhance the improvement capabilities of feedback recipients to increase the uptake of insulin pumps in line with NICE guidance. This evidence concerns the gene INS and diabetes mellitus.